BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 16688745)

  • 1. MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia.
    Eguchi M; Eguchi-Ishimae M; Knight D; Kearney L; Slany R; Greaves M
    Genes Chromosomes Cancer; 2006 Aug; 45(8):754-60. PubMed ID: 16688745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
    Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
    Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo.
    Takacova S; Slany R; Bartkova J; Stranecky V; Dolezel P; Luzna P; Bartek J; Divoky V
    Cancer Cell; 2012 Apr; 21(4):517-31. PubMed ID: 22516260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
    Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
    Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
    Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
    Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
    Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
    Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
    Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
    Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of hematopoietic progenitor cell immortalization by MLL-ENL.
    Horton SJ; Williams O
    Cell Cycle; 2006 Feb; 5(4):360-2. PubMed ID: 16479159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene.
    Ninomiya M; Abe A; Yokozawa T; Ozeki K; Yamamoto K; Ito M; Ito M; Kiyoi H; Emi N; Naoe T
    Cancer Genet Cytogenet; 2006 Aug; 169(1):1-11. PubMed ID: 16875930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
    He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.
    Horton SJ; Walf-Vorderwülbecke V; Chatters SJ; Sebire NJ; de Boer J; Williams O
    Blood; 2009 May; 113(20):4922-9. PubMed ID: 19029444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel infant acute lymphoblastic leukemia cell line with MLL-AF5q31 fusion transcript.
    Imamura T; Morimoto A; Ikushima S; Kakazu N; Hada S; Tabata Y; Yagi T; Inaba T; Hibi S; Sugimoto T; Imashuku S
    Leukemia; 2002 Nov; 16(11):2302-8. PubMed ID: 12399976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4.
    Ono R; Ihara M; Nakajima H; Ozaki K; Kataoka-Fujiwara Y; Taki T; Nagata K; Inagaki M; Yoshida N; Kitamura T; Hayashi Y; Kinoshita M; Nosaka T
    Mol Cell Biol; 2005 Dec; 25(24):10965-78. PubMed ID: 16314519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.